Q32 Bio Inc. 8-K

What Happened
Q32 Bio Inc. (ticker: QTTB) filed a Form 8-K on May 5, 2026 to announce its financial results for the quarter ended March 31, 2026 and to provide a corporate update. The company furnished a press release with the announcement (Exhibit 99.1). The filing notes the furnished information is not being “filed” for purposes of Section 18 of the Exchange Act. The report was signed by CEO Jodie Morrison on May 5, 2026.

Key Details

• Filing: Form 8-K dated May 5, 2026 (Accession No. 0001193125-26-205006).
• Period covered: Quarterly results for the quarter ended March 31, 2026.
• Press release: Issued May 5, 2026 and furnished as Exhibit 99.1 to the 8-K.
• Legal note: The information is furnished (not “filed”) under the Exchange Act; the cover page XBRL exhibit is included.

Why It Matters
This notice signals Q32 Bio’s latest quarterly earnings and operational update — essential for investors tracking the company’s revenue, expenses and progress. Because the press release is furnished rather than filed, investors should read Exhibit 99.1 for details and watch for subsequent filed reports (e.g., 10-Q) for the official, audited financial statements and fuller disclosure. Monitor the company’s upcoming filings and public statements for concrete earnings, revenue, or guidance figures.